(Reuters) - Europe's biggest drugmaker said Cervarix, one of its biggest
new drug hopes, had been approved for use in women aged 10 to 45
years old.
Glaxo expects to launch Cervarix in Europe later this year
but it may not get to market in the United States before 2008.
Read more at Reuters.com Government Filings News
new drug hopes, had been approved for use in women aged 10 to 45
years old.
Glaxo expects to launch Cervarix in Europe later this year
but it may not get to market in the United States before 2008.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment